Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Ribosome,6.149524081375692e-37,42.367924528301884,3532.6067773416626,"['RPL10', 'RPL34', 'RPL12', 'RPLP1', 'RPL11', 'RPL36A', 'RPS27L', 'RPL10A', 'RPL9', 'RPL7', 'RPS15', 'RPS14', 'RPS15A', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL14', 'RPS3', 'RPL38', 'RPS2', 'RPL18', 'RPS10', 'RPL17', 'RPS13', 'RPS12', 'RPL41', 'RPS7', 'RPL21', 'RPSA', 'RPS3A', 'MRPL24', 'RPS28', 'RPL22L1', 'FAU', 'RPL26']",3.136257281501603e-35,0,0,36
2,Coronavirus disease,4.014726980926173e-32,30.022222222222222,2170.3891145509974,"['RPL10', 'RPL34', 'RPL12', 'RPLP1', 'RPL11', 'RPL36A', 'RPS27L', 'RPL10A', 'RPL9', 'RPL7', 'RPS15', 'RPS14', 'RPS15A', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL14', 'RPS3', 'RPL38', 'RPS2', 'RPL18', 'RPS10', 'RPL17', 'RPS13', 'RPS12', 'RPL41', 'RPS7', 'RPL21', 'RPSA', 'RPS3A', 'RPS28', 'RPL22L1', 'FAU', 'RPL26']",1.023755380136174e-30,0,0,35
3,Protein export,0.0333085967968599,8.135632183908045,27.67693054422408,"['SRPRA', 'SEC11C']",0.48337372311076876,0,0,2
4,alpha-Linolenic acid metabolism,0.04833583115896138,40.31818181818182,122.14724385255813,['ACOX3'],0.48337372311076876,0,0,1
5,Pyrimidine metabolism,0.05054571792294241,6.252873563218391,18.6640587756295,"['NT5C', 'NME1']",0.48337372311076876,0,0,2
6,PPAR signaling pathway,0.05686749683656103,5.804597701149425,16.64196349142623,"['DBI', 'ACOX3']",0.48337372311076876,0,0,2
7,Peroxisome,0.08459091436640152,4.509578544061303,11.13833617813584,"['PMVK', 'ACOX3']",0.5077728417905404,0,0,2
8,Propanoate metabolism,0.11654033861850614,10.071022727272727,21.647842734030696,['ACOX3'],0.5077728417905404,0,0,1
9,Terpenoid backbone biosynthesis,0.1381830010014274,8.054545454545455,15.941366099953546,['PMVK'],0.5077728417905404,0,0,1
10,Galactose metabolism,0.1381830010014274,8.054545454545455,15.941366099953546,['GALT'],0.5077728417905404,0,0,1
11,Amino sugar and nucleotide sugar metabolism,0.15930128369899305,6.7102272727272725,12.32640569544685,['GALT'],0.5077728417905404,0,0,1
12,Biosynthesis of unsaturated fatty acids,0.15930128369899305,6.7102272727272725,12.32640569544685,['ACOX3'],0.5077728417905404,0,0,1
13,Mucin type O-glycan biosynthesis,0.15930128369899305,6.7102272727272725,12.32640569544685,['GALNT13'],0.5077728417905404,0,0,1
14,Nicotinate and nicotinamide metabolism,0.15930128369899305,6.7102272727272725,12.32640569544685,['NT5C'],0.5077728417905404,0,0,1
15,beta-Alanine metabolism,0.15930128369899305,6.7102272727272725,12.32640569544685,['ACOX3'],0.5077728417905404,0,0,1
16,Fatty acid degradation,0.15930128369899305,6.7102272727272725,12.32640569544685,['ACOX3'],0.5077728417905404,0,0,1
17,Spliceosome,0.17482743957452704,2.7903289734443124,4.866210539758068,"['NCBP2', 'SNRPE']",0.5204117634222527,0,0,2
18,RNA transport,0.18367474003138332,2.696551724137931,4.569546358029173,"['NCBP2', 'RPP21']",0.5204117634222527,0,0,2
19,Purine metabolism,0.2015561627125367,2.526580459770115,4.046791615768068,"['NT5C', 'NME1']",0.5302271431464045,0,0,2
20,Other types of O-glycan biosynthesis,0.21963401014189843,4.46969696969697,6.775134074515796,['GALNT13'],0.5302271431464045,0,0,1
21,Oxidative phosphorylation,0.22464512576725207,1.8995276162790697,2.836437968225227,"['ATP5PF', 'UQCRQ', 'ATP5F1E']",0.5302271431464045,0,0,3
22,Cellular senescence,0.228725434298449,2.3080459770114943,3.40490552534465,"['CAPN2', 'E2F4']",0.5302271431464045,0,0,2
23,mRNA surveillance pathway,0.27568213372995115,3.3494318181818183,4.315765561165562,['NCBP2'],0.5800123377017592,0,0,1
24,GnRH secretion,0.27568213372995115,3.3494318181818183,4.315765561165562,['HCN1'],0.5800123377017592,0,0,1
25,Diabetic cardiomyopathy,0.2843197733832153,1.66103854730806,2.089014616250371,"['ATP5PF', 'UQCRQ', 'ATP5F1E']",0.5800123377017592,0,0,3
26,TGF-beta signaling pathway,0.3108167635328292,2.8693181818181817,3.3529467115755285,['E2F4'],0.5845471784848485,0,0,1
27,Prolactin signaling pathway,0.3108167635328292,2.8693181818181817,3.3529467115755285,['GALT'],0.5845471784848485,0,0,1
28,Alzheimer disease,0.3209278626975639,1.4309213951067152,1.6262978396936847,"['ATP5PF', 'UQCRQ', 'CAPN2', 'ATP5F1E']",0.5845471784848485,0,0,4
29,Ribosome biogenesis in eukaryotes,0.34426533582011964,2.5092329545454546,2.6757019773704407,['NOP10'],0.6054321423043483,0,0,1
30,Drug metabolism,0.3761078860345874,2.2291666666666665,2.179855818775878,['NME1'],0.6235375454274538,0,0,1
31,Thermogenesis,0.37901301780884444,1.38813151563753,1.3467439951349331,"['ATP5PF', 'UQCRQ', 'ATP5F1E']",0.6235375454274538,0,0,3
32,Insulin secretion,0.44917971172883064,1.742094861660079,1.3942546524013368,['RIMS2'],0.664382964256267,0,0,1
33,Pathways of neurodegeneration,0.460946618481979,1.1631713554987213,0.9008448531054692,"['ATP5PF', 'UQCRQ', 'CAPN2', 'ATP5F1E']",0.664382964256267,0,0,4
34,Parkinson disease,0.4711384510310828,1.190881878885563,0.8962616044824923,"['ATP5PF', 'UQCRQ', 'ATP5F1E']",0.664382964256267,0,0,3
35,Cell cycle,0.4759787665616603,1.6018181818181818,1.1891610396110974,['E2F4'],0.664382964256267,0,0,1
36,Huntington disease,0.47750880484695246,1.1788645690834474,0.8713844826050614,"['ATP5PF', 'UQCRQ', 'ATP5F1E']",0.664382964256267,0,0,3
37,Glutamatergic synapse,0.5014879063968073,1.4823232323232323,1.0230636030608677,['GRIK2'],0.664382964256267,0,0,1
38,Protein processing in endoplasmic reticulum,0.5076925055740846,1.1947160747984218,0.8098733187790085,"['CAPN2', 'PDIA6']",0.664382964256267,0,0,2
39,Apoptosis,0.5137780650927278,1.4289772727272727,0.9516472586171887,['CAPN2'],0.664382964256267,0,0,1
40,Prion disease,0.5210846778480526,1.1009174311926606,0.7176250139189919,"['ATP5PF', 'UQCRQ', 'ATP5F1E']",0.664382964256267,0,0,3
41,Focal adhesion,0.5488792106620698,1.2895894428152492,0.7735948897461431,['CAPN2'],0.6770850900469392,0,0,1
42,Amyotrophic lateral sclerosis,0.5684421364845846,1.0232558139534884,0.5779919340805477,"['ATP5PF', 'UQCRQ', 'ATP5F1E']",0.6770850900469392,0,0,3
43,Cardiac muscle contraction,0.5708756641572231,1.2107438016528926,0.6787234145211203,['UQCRQ'],0.6770850900469392,0,0,1
44,Necroptosis,0.591811044210034,1.1409090909090909,0.5984842598110437,['CAPN2'],0.6859628012434487,0,0,1
45,cAMP signaling pathway,0.6213346995201702,1.04994019138756,0.49965118024512295,['ACOX3'],0.7041793261228595,0,0,1
46,Neuroactive ligand-receptor interaction,0.6901352249221857,0.8653656126482213,0.3209361738441553,['GRIK2'],0.7651499232832929,0,0,1
47,Pathogenic Escherichia coli infection,0.7400959075265747,0.7495711835334476,0.22560255906329707,['RPS3'],0.8030827932735172,0,0,1
48,Non-alcoholic fatty liver disease,0.7927879069173803,0.6391129032258065,0.14840172834844034,['UQCRQ'],0.8305156775774093,0,0,1
49,Shigellosis,0.7979464353194716,0.6287878787878788,0.14192610619649737,['CAPN2'],0.8305156775774093,0,0,1
50,Salmonella infection,0.8651451589598701,0.4991369390103567,0.07230396488655816,['RPS3'],0.8685183817768763,0,0,1
51,Herpes simplex virus 1 infection,0.8685183817768763,0.4927556818181818,0.06946205789139297,['ZNF630'],0.8685183817768763,0,0,1
